✦ LIBER ✦

Malignant lymphoma (so-called reticulum cell sarcoma) of bone

✍ Scribed by Dr. H. Chester Boston Jr.; David C. Dahlin; John C. Ivins; Roger E. Cupps

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 744 KB
Volume: 34
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197410)34:4<1131::aid-cncr2820340424>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of reticulosarcoma (reticulum-cel

A case of reticulosarcoma (reticulum-cell sarcoma) of bone

✍ A. T. Fripp; H. A. Sissons 📂 Article 📅 1954 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

Primary reticulum cell sarcoma of bone.

Primary reticulum cell sarcoma of bone. With emphasis on radiation therapy

✍ C. C. Wang; Donald J. Fleischli 📂 Article 📅 1968 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 2 views

Radioactive phosphorus. III. In the trea

Radioactive phosphorus. III. In the treatment of malignant lymphomas, plasma-cell myeloma, Ewing's sarcoma, and osteogenic sarcoma

✍ Henry D. Diamond; Lloyd F. Craver; Helen Q. Woodard 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 816 KB

Primary malignant melanoma (clear cell s

Primary malignant melanoma (clear cell sarcoma) of bone: Report of a case arising in the ulna

✍ Ryohei Yokoyama; Kiyoshi Mukai; Teruyuki Hirota; Yasuo Beppu; Hisatoshi Fukuma 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 2 views

## BACKGROUND. To the authors' knowledge, there has been no previous report of primary maligiiant melanoma of bone. ## METHODS. A 33-year-old woman presented with a tumorous lesion in the olecranon of the right ulna. The histologic diagnosis was malignant melanoma with close similarity to clear

Acquired expression of myeloid lineage-a

Acquired expression of myeloid lineage-associated antigens in T-cell malignant lymphoma showing bone marrow relapse

✍ Yoshie Hashimoto; Masaki Yasukawa; Kiyonori Takada; Takaaki Hato; Shigeru Fujita 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

A phase II trial of human recombinant ln

A phase II trial of human recombinant lnterleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A childrens cancer group study

✍ Madeline Bauer; Gregory H. Reaman; Jacquelyn A. Hank; Mitchell S. Cairo; Peter A 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB